Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Kotliarova Website

Svetlana Kotliarova, Ph.D.

Selected Publications
1)  Kreisl TN, Kotliarova S, Butman JA, Albert PS, Kim L, Musib L, Thornton D, Fine HA.
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas.
Neuro-oncology. 12: 181-9, 2010. [Journal]
2)  Kreisl TN, Kim L, Moore K, Duic P, Kotliarova S, Walling J, Musib L, Thornton D, Albert PS, Fine HA.
A phase I trial of enzastaurin in patients with recurrent gliomas.
Clin. Cancer Res. 15: 3617-23, 2009. [Journal]
3)  Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed ME, Su Q, Center A, Zenklusen JC, Fine HA.
Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes.
Cancer Res. 69: 1596-603, 2009. [Journal]
4)  Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA.
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.
Cancer Cell. 13: 69-80, 2008. [Journal]
5)  Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA.
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.
Cancer Res. 68: 6643-51, 2008. [Journal]
6)  Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA.
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.
Cancer Cell. 9: 391-403, 2006. [Journal]
7)  Jana NR, Dikshit P, Goswami A, Kotliarova S, Murata S, Tanaka K, Nukina N.
Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes.
J. Biol. Chem. 280: 11635-40, 2005. [Journal]
8)  Kotliarova S, Jana NR, Sakamoto N, Kurosawa M, Miyazaki H, Nekooki M, Doi H, Machida Y, Wong HK, Suzuki T, Uchikawa C, Kotliarov Y, Uchida K, Nagao Y, Nagaoka U, Tamaoka A, Oyanagi K, Oyama F, Nukina N.
Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates.
J. Neurochem. 93: 641-53, 2005. [Journal]
9)  Bauer PO, Kotliarova SE, Matoska V, Musova Z, Hedvicakova P, Boday A, Tomek A, Nukina N, Goetz P.
Fluorescent multiplex PCR--fast method for autosomal dominant spinocerebellar ataxias screening.
Genetika. 41: 830-7, 2005. [Journal]
10)  Amano K, Sago H, Uchikawa C, Suzuki T, Kotliarova SE, Nukina N, Epstein CJ, Yamakawa K.
Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Hum. Mol. Genet. 13: 1333-40, 2004. [Journal]
11)  Oyama F, Kotliarova S, Harada A, Ito M, Miyazaki H, Ueyama Y, Hirokawa N, Nukina N, Ihara Y.
Gem GTPase and tau: morphological changes induced by gem GTPase in cho cells are antagonized by tau.
J. Biol. Chem. 279: 27272-7, 2004. [Journal]
12)  Lee J, Kotliarova SE, Ewis AA, Hida A, Shinka T, Kuroki Y, Tokunaga K, Nakahori Y.
Y chromosome compound haplotypes with the microsatellite markers DXYS265, DXYS266, and DXYS241.
J. Hum. Genet. 46: 80-4, 2001. [Journal]
13)  Wang G, Sawai N, Kotliarova S, Kanazawa I, Nukina N.
Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B.
Hum. Mol. Genet. 9: 1795-803, 2000. [Journal]
14)  Wang GH, Mitsui K, Kotliarova S, Yamashita A, Nagao Y, Tokuhiro S, Iwatsubo T, Kanazawa I, Nukina N.
Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells.
Neuroreport. 10: 2435-8, 1999. [Journal]
15)  Shinka T, Tomita K, Toda T, Kotliarova SE, Lee J, Kuroki Y, Jin DK, Tokunaga K, Nakamura H, Nakahori Y.
Genetic variations on the Y chromosome in the Japanese population and implications for modern human Y chromosome lineage.
J. Hum. Genet. 44: 240-5, 1999. [Journal]
16)  Kotliarova SE, Toda T, Takenaka O, Matsushita I, Hida A, Shinka T, Goto J, Tokunaga K, Nakagome Y, Nakahori Y.
Novel (CA)n marker DXYS241 on the nonrecombinant part of the human Y chromosome.
Hum. Biol. 71: 261-75, 1999. [Journal]
17)  Kuroki Y, Iwamoto T, Lee J, Yoshiike M, Nozawa S, Nishida T, Ewis AA, Nakamura H, Toda T, Tokunaga K, Kotliarova SE, Kondoh N, Koh E, Namiki M, Shinka T, Nakahori Y.
Spermatogenic ability is different among males in different Y chromosome lineage.
J. Hum. Genet. 44: 289-92, 1999. [Journal]
18)  Kotliarova SE, Toda T, Matsushita I, Nakagome Y, Nakahori Y.
A novel (CA)n polymorphism on 6p21.1-21.2.
Jpn. J. Hum. Genet. 41: 423-5, 1996. [Journal]
19)  Kotliarova SE, Krasnova IA, Kovalenko SP.
[Evaluation of allele frequency of the hypervariable locus D17S30 in a sample of populations of European origin from a number of Siberian regions].
Genetika. 31: 573-7, 1995. [Journal]
20)  Kotliarova SE, Kovalenko SP, Sharonova DA, Novoselov VP.
[The use of the polymerase chain reaction method for the analysis of polymorphic sections of the human genome in performing forensic medical expertise on material evidence].
Sud. Med. Ekspert. 37: 19-21, 1994. [Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 12/9/2011.